Zeinab A. Afify, MD

Zeinab A. Afify, MD

Hematology/Oncology - Pediatric

Offers My Health Connected Health Record
Accepting New Patients
Patient Satisfaction

()

Patient Satisfaction

No ratings yet? Why?

Office Location

Main Office
Accepting new patients
Mon thru Fri 8AM - 5PM
SelectHealth Plans
  • CHIP
  • Community Care
  • Select Care
  • Select Choice
  • Select Med
  • SelectHealth Share

Note: This list only shows the SelectHealth plans accepted by the provider. Contact the provider's office to learn what other insurance plans are accepted.

More

Professional Summary

Degree

  • University Of Alexandria in Doctor of Medicine, 1980
Training
  • Internship: University Of Alexandria, 1981 - 1982
  • Residency: University Of Alexandria, 1983 - 1986
  • Residency: Riley Hospital For Sick Children - Indianapolis, IN, 1994 - 1995
  • Fellowship: Riley Hospital For Sick Children - Indianapolis, IN, 1993 - 1994
  • Fellowship: University of Iowa Hospitals & Clinics - Iowa City, IA, 1992 - 1993
Professional Memberships
  • American Society of Clinical Oncology
  • American Society for Pediatric Hema/Oncol
  • American Society of Hematology
Professional Positions
  • 1986-1990 Assistant Lecturer of Pediatrics Department of Pediatrics, University of Alexandria, Egypt\n1990-1992 And 1995-1996 Lecturer of Pediatrics, University of Alexandria Children Hospital, University of Alexandria, Egypt\n1998- 2001 Pediatric Hematologist/Oncologist,Department of Pediatrics, Tawam Hospital , UAE 2002-2008 Assistant Professor, 2008-present: Pediatric Hematology/Oncology, University of Utah. International Held Pediatric Hematology Oncology positions in UK and Australia
Languages Spoken
  • English
  • Arabic

Intermountain Hospital Affiliations

Personal Bio & Interests

University of Utah:Member of: Clinical Cancer Investigation Committee (CCIC), 2004- 2006. Data and Safety Monitoring Committee (DSMC) 2006- present, Huntsman Cancer Institute . Pediatric Hematology Oncology fellowship Program Director, 2007- 2009. Institutional review Board (IRB), 2007- Present: Children's Oncology Group (COG) Member of these committees: 1)Non Hodgkin Lymphoma . 2) Rare NHL Registry (ANHL04B1)
3) A Phase I/II Pilot Study of ICE and SGN-30 in children with CD30 Positive Recurrent Anaplastic Large Cell Lymphomas (ALCL), (ANHL06P1).

Verified Patient Ratings

The Patient Rating score is an average of all responses to physician related questions on the nationally developed CAHPS Clinician & Group Survey (CG-CAHPS). Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about the survey

Verified Patient Comments

Comments also are gathered from the CG-CAHPS survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.